Loading company details...
Beta
Latest Form 4 (Jul 7, 2026): Matthew C. Kapusta (CEO, Managing Director): Exercise/Conversion of 21,082 shares, $408.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 7, 2026 | Matthew C. Kapusta, CEO, Managing Director | Exercise/Conversion | 21,082 | $408.8K |
| Jul 2, 2026 | Walid Abi-Saab, Chief Medical Officer | Exercise/Conversion | 10,000 | $55.9K |
| Jul 2, 2026 | Jack Kaye | Exercise/Conversion | 4,107 | $152.0K |
| Jun 30, 2026 | Walid Abi-Saab, Chief Medical Officer | Sale | 1,434 | $67.2K |
| Jun 26, 2026 | Matthew C. Kapusta, CEO, Managing Director | Exercise/Conversion | 4,128 | $130.9K |
| Jun 22, 2026 | Matthew C. Kapusta, CEO, Managing Director | Exercise/Conversion | 62,581 | $1.21M |
| Jun 22, 2026 | Madhavan Balachandran | Exercise/Conversion | 5,295 | $167.9K |
| Jun 22, 2026 | Jack Kaye | Exercise/Conversion | 5,295 | $167.9K |
| Jun 17, 2026 | Madhavan Balachandran | Exercise/Conversion | 10,000 | $84.9K |
| Jun 17, 2026 | Jeannette Potts, Chief Legal Officer | Sale | 5,237 | $144.9K |